Background: Circular RNAs (circRNAs) are receiving increasing attention as novel biomarkers. Our goal was to investigate the diagnostic, clinicopathological, and prognostic utility of circRNAs in prostate cancer (PCa).
Methods: Relevant literature was searched in PubMed, Web of Science, and EMBASE.